Activation of the hepatic LDL receptor promoter by thyroid hormone

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1771, Issue 9, 2007, Pages 1216-1225

  Lopez, Dayami ^a   Abisambra Socarrás, Jose F ^a   Bedi, Mohini ^a   Ness, Gene C ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Cholesterol domeostasis; LDL receptor promoter activity; Rat liver; SREBP 2; Sterol response element; Thyroid hormone response element; Thyroid receptor 1

Indexed keywords

CELL EXTRACT; CHOLESTEROL; LIOTHYRONINE; LOW DENSITY LIPOPROTEIN RECEPTOR; NUCLEAR PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; THYROID HORMONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; DRUG MECHANISM; GEL MOBILITY SHIFT ASSAY; GENE DELETION; HYPOPHYSECTOMY; HYPOTHYROIDISM; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; RAT; RECEPTOR UPREGULATION; REPORTER GENE; THYROIDECTOMY; TRANSCRIPTION INITIATION; TREATMENT RESPONSE; WESTERN BLOTTING;

ANIMALS; GENES, REPORTER; HUMANS; HYPOPHYSECTOMY; LIVER; MALE; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, LDL; RESPONSE ELEMENTS; RETINOID X RECEPTOR ALPHA; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; THYROID HORMONE RECEPTORS BETA; THYROIDECTOMY; TISSUE EXTRACTS; TRETINOIN; TRIIODOTHYRONINE;

ANIMALIA; RATTUS;

EID: 34548640881     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2007.05.001     Document Type: Article

References (56)

1. Brown B.G. Contemporary Insights, Cholesterol Metabolism and its Regulation (2003)
2. Walton K.W., Campbell D.A., and Tonks E.L. The significance of alterations in serum lipids in thyroid dysfunction, I. The relation between serum lipoproteins, carotenoids and vitamin A in hypothyroidism and thyrotoxicosis. Clin. Sci. 29 (1965) 199-215
3. Illingworth D., McClung M.R., Conner W.E., and Alaupovic P. Familial hypercholesterolaemia and primary hypothyroidism: coexistence of both disorders in a young woman with severe hypercholesterolaemia. Clin. Endocrinol. 14 (1981) 145-152
4. Ness G.C., Pendleton L.C., Li Y.C., and Chiang J.Y.L. Effect of thyroid hormone on hepatic cholesterol 7α hydroxylase, LDL receptor, HMG-CoA reductase, farnesyl pyrophosphate synthase and apolipoprotein A-I mRNA levels in hypophysectomized rats. Biochem. Biophys. Res. Commun. 172 (1990) 1150-1156
5. Cappola A.R., and Ladenson P.W. Hypothyroidism and atherosclerosis. J. Clin. Endocrinol. Metab. 88 (2003) 2438-2444
6. Hansson P., Valdemarsson S., and Nilsson-Ehle P. Experimental hyperthyroidism in man. Effects on plasma lipoproteins, lipoprotein lipase and hepatic lipase. Horm. Metab. Res. 15 (1983) 449-452
7. Ness G.C. Thyroid hormone: basis for its hypocholesterolemic effect. J. Fla. Med. Assoc. 78 (1991) 383-385
8. Underwood A.H., Emmett J.C., Ellis D., Flynn S., Leeson B., Benson G.M., Novelli R., Pearce N.J., and Shaw V.P. A thyromimetics that decreases plasma cholesterol levels without increasing cardiac activity. Nature 324 (1986) 425-429
9. 3 by liver targeting with cholic acid. Biochem. Pharmacol. 43 (1992) 1969-1974
10. Steele R.E., Wasvary J.M., Dardik B.N., Schwarzkopf C.D., Sharif R., Leonards K.S., Hu C.W., Yuracheck E.C., and Stephan Z.F. CGS-26214, the thyroxine connection revisited. In: Woodford F.P., Davignon J., and Sniderman A. (Eds). Atherosclerosis X (1995), Elsevier, New York 321-324
11. Engelken S.F., and Eaton R.P. The effects of altered thyroid status on lipid metabolism in the genetic hyperlipemic Zucker rat. Atherosclerosis 38 (1981) 177-188
12. Aviram M., Luboshitzky R., and Brook J.G. Lipid and lipoprotein patterns in thyroid dysfunction and the effect of therapy. Clin. Biochem. 15 (1982) 62-66
13. Thompson G.R., Soutar A.K., Spengel F.A., Jadhav A., Gavigan S.J.P., and Myant N.B. Defects of receptor-mediated low density lipoprotein catabolism in homozygous familial hypercholesterolemia and hypothyroidism in vivo. Proc. Natl. Acad. Sci. U. S. A. 78 (1981) 2591-2595
14. Leeson P.D., Emmett J.C., Shah V.P., Showell G.A., Novelli R., Prain H.D., Benson M.G., Ellis D., Pearce N.J., and Underwood A.H. Selective thyromimetics. Cardiac-sparing thyroid hormone analogues containing 3′-arylmethyl substituents. J. Med. Chem. 32 (1989) 320-336
15. Walton K.W., Scott P.J., Dykes P.W., and Davies J.W.L. The significance of alterations in serum lipids in thyroid dysfunction, II. Alterations of the metabolism and turnover of 131-I-low-density lipoproteins in hypothyroidism and thyrotoxicosis. Clin. Sci. 29 (1965) 217-238
16. Morkin E., Ladenson P., Goldman S., and Adamson C. Thyroid hormone analogs for treatment of hypercholesterolemia and heart failure: past, present and future prospects. J. Mol. Cell. Cardiol. 37 (2004) 1137-1146
17. Ness G.C., Lopez D., Chambers C.M., Newsome W.P., Cornelius P., Long C.A., and Harwood H.J. Effects of l-triiodothyronine and the thyromimetric L-94901 on serum lipoprotein levels and hepatic low-density lipoprotein receptor, 3-hydroxy-3-methylglutaryl coenzyme A reductase, and apo A-I gene expression. Biochem. Pharmacol. 56 (1998) 121-129
18. Salter A.M., Hayashi R., Al-Seeni M., Brown N.F., Bruce J., Sorensen O., Atkinson A., Middleton B., Bleackley R.C., and Brindley D.N. Effects of hypothyroidism and high-fat feeding on mRNA concentrations for the low-density lipoprotein receptor and on acyl-CoA:cholesterol acyltransferase activities in rat liver. Biochem. J. 276 (1991) 825-832
19. Ness G.C., and Zhao Z. Thyroid hormone rapidly induces hepatic LDL receptor mRNA levels in hypophysectomized rats. Arch. Biochem. Biophys. 315 (1994) 199-202
20. Staels B., Van Tol A., Chan L., Will H., Verhoeven G., and Auwerx J. Alterations in thyroid status modulate apolipoprotein, hepatic triglyceride lipase, and low density lipoprotein receptor in rats. Endocrinology 127 (1990) 1144-1152
21. Hudig H., Bakker O., and Wiersinga W.N. Triiodothyronine prevents the amiodarone-induced decrease in the expression of the liver low-density lipoprotein receptor gene. J. Endocrinol. 152 (1997) 413-421
22. Ness G.C., and Lopez D. Transcriptional regulation of rat hepatic low-density lipoprotein receptor and cholesterol 7α hydroxylase by thyroid hormone. Arch. Biochem. Biophys. 323 (1995) 404-408
23. Dueland S., Drisko J., Graf L., Machleder D., Lusis A.J., and Davis R.A. Effect of dietary cholesterol and taurocholate on cholesterol 7α-hydroxylase and hepatic LDL receptors in inbred mice. J. Lipid Res. 34 (1993) 923-931
24. Mistry P., Miller N.E., Laker M., Hazzard W.R., and Lewis B. Individual variation in the effects of dietary cholesterol on plasma lipoproteins and cellular cholesterol homeostasis in man. Studies of low density lipoprotein receptor activity and 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in blood mononuclear cells. J. Clin. Invest. 67 (1981) 493-502
25. Applebaum-Bowden D., Haffner S.M., Hartsook E., Luk K.H., Alberts J.J., and Hazzard W.R. Down-regulation of the low-density lipoprotein receptor by dietary cholesterol. Am. J. Clin. Nutr. 39 (1984) 360-367
26. Hennessy L.K., Osada J., Ordovas J.M., Nicolosi R.J., Stucchi A.F., Brousseau M.E., and Schaefer E.J. Effects of dietary fats and cholesterol on liver lipid content and hepatic apolipoproteins A-I, B, and E and LDL receptor mRNA levels in cebus monkeys. J. Lipid Res. 33 (1992) 351-360
27. Kovanen P.T., Brown M.S., Basu S.K., Billheimer D.W., and Goldstein J.L. Saturation and suppression of hepatic lipoprotein receptors: a mechanism for the hypercholesterolemia of cholesterol-fed rabbits. Proc. Natl. Acad. Sci. U. S. A. 78 (1981) 1396-1400
28. Rudling M., and Angelin B. Loss of resistance to dietary cholesterol in the rat after hypophysectomy: importance of the presence of growth hormone for hepatic low density lipoprotein-receptor expression. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 8851-8855
29. Goldstein J.L., and Brown M.S. Regulation of the mevalonate pathway. Nature 343 (1990) 425-430
30. Südhof T.C., Russell D.W., Brown M.S., and Goldstein J.L. 42 bp element from LDL receptor gene confers end-product repression by sterols when inserted into viral TK promoter. Cell 48 (1987) 1061-1069
31. Bishop R.W. Structure of the hamster low density lipoprotein receptor gene. J. Lipid Res. 33 (1992) 549-557
32. Hoffer M.J.V., van Eck M.M., Petris F., van der Zee A., de Wit E., Meijer D., Grosveld G., Havekes L.M., Hofker M.H., and Frants R.R. The mouse low density lipoprotein receptor gene: cDNA sequence and exon-intron structure. Biochem. Biophys. Res. Commun. 191 (1993) 880-886
33. Mehta K.D., Brown M.S., Bilheimer D.W., and Goldstein J.L. The low density lipoprotein receptor in Xenopus laevis, II. Feedback repression mediated by conserved sterol regulatory element. J. Biol. Chem. 266 (1991) 10415-10419
34. Osborne T.F. Transcriptional control mechanisms in the regulation of cholesterol balance. Crit. Rev. Euk. Gene Exp. 5 (1995) 317-335
35. Magana M.M., and Osborne T.F. Two tandem binding sites for sterol regulatory element binding proteins are required for sterol regulation of fatty-acid synthase promoter. J. Biol. Chem. 271 (1996) 32689-32694
36. Ericsson J., Jackson S.M., Lee B.C., and Edwards P.A. Sterol regulatory element binding protein binds to a cis element in the promoter of the farnesyl diphosphate synthase gene. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 945-950
37. Sato R., Inoue J., Kawabe Y., Kodama T., Takano T., and Maeda M. Sterol-dependent transcriptional regulation of sterol regulatory element-binding protein-2. J. Biol. Chem. 271 (1996) 26461-26464
38. Hua X., Yokoyama C., Wu J., Briggs M.R., Brown M.S., Goldstein J.L., and Wang X. SREBP-2, a second basic-helix-loop-helix-leucine zipper protein that stimulates transcription by binding to a sterol regulatory element. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 11603-11607
39. Yokoyama C., Wang X., Briggs M.R., Admon A., Wu J., Hua X., Goldstein J.L., and Brown M.S. SREBP-1, a basic helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene. Cell 75 (1993) 187-197
40. Briggs M.R., Yokoyama C., Wang X., Brown M.S., and Goldstein J.L. Nuclear protein that binds sterol regulatory element of low density lipoprotein receptor promoter, I. Identification of the protein and delineation of its target nucleotide sequence. J. Biol. Chem. 268 (1993) 14490-14496
41. Wang X., Sato R., Brown M.S., Hua X., and Goldstein J.L. SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis. Cell 77 1994 (1994) 53-62
42. Sato R., Yang J., Wang X., Evans M.J., Ho Y.K., Goldstein J.L., and Brown M.S. Assignment of the membrane attachment, DNA binding, and transcriptional activation domains of sterol regulatory element binding protein-1 (SREBP-1). J. Biol. Chem. 269 (1994) 17267-17273
43. Shimano H. Sterol regulatory element-binding proteins (SREBPs): transcriptional regulators of lipid synthetic genes. Prog. Lipid Res. 40 (2001) 439-452
44. Hua X., Sakai J., Ho Y.K., Goldstein J.L., and Brown M.S. Hairpin orientation of sterol regulatory element binding protein-2 in cell membranes as determined by protease protection. J. Biol. Chem. 270 (1995) 29422-29427
45. Shin D.J., and Osborne T.F. Thyroid hormone regulation and cholesterol metabolism are connected through Sterol Regulatory Element-Binding Protein-2 (SREBP-2). J. Biol. Chem. 278 (2003) 34114-34118
46. Yu C.L., Meyer D.J., Campbell G.S., Larner A.C., Carter-Su C., Schwartz J., and Jove R. Enhanced DNA-binding activity of Stat3-related protein in cells transformed by the Src oncoprotein. Science 269 (1995) 81-83
47. Lopez D., and Ness G.C. Characterization of the rat LDL receptor 5′-flanking region. Biochim. Biophys. Acta 1761 (2006) 492-500
48. Petty K.J., Desvergne B., Mitsuhashi T., and Nikodem V.M. Identification of a thyroid hormone response element in the malic enzyme gene. J. Biol. Chem. 265 (1990) 7395-7400
49. Samuels H.H., Stanley F., and Casanova J. Depletion of l-3,5,3′-triiodothyronine and l-thyroxine in euthyroid calf serum for use in cell culture studies of the action of thyroid hormone. Endocrinology 105 (1979) 80-85
50. Lopez D., Irby R.B., and McLean M.P. Peroxisome proliferator-activated receptor α induces rat sterol carrier protein X promoter activity through two peroxisome proliferator-response elements. Mol. Cell. Endocrinol. 205 (2003) 169-184
51. Zar J.H. In: McElroy W.D., and Swanson C.P. (Eds). Biostatistical Analysis (1974), Prentice-Hall, Englewood Cliffs, NJ 101-127 (Chapters 9 and 10)
52. Lopez D., Sandhoff T.W., and McLean M.P. Steroidogenic factor-1 mediates cyclic 3′,5′-adenosine monophosphate regulation of the high density lipoprotein receptor. Endocrinology 140 (1999) 3034-3044
53. Bakker O., Hudig F., Meijssen S., and Wiersinga W.M. Effects of triiodothyronine and amiodarone on the human LDL receptor gene. Biochem. Biophys. Res. Commun. 249 (1998) 517-521
54. Zandieh Doulabi B., Platvoet-ter Schiphorst M., van Beeren H.C., Labruyere W.T., Lamers W.H., Fliers E., Bakker O., and Wiersinga W.M. TRb1 protein is preferentially expressed in the pericentral zone of rat liver and exhibits marked diurnal variation. Endocrinology 143 (2002) 979-984
55. Flamant F., and Samarut J. Thyroid hormone receptors: lessons from knockout and knock-in mutant mice. Trends Endocrinol. Metab. 14 (2003) 85-90
56. Murray M.B., Zilz N.D., McCreary N.L., MacDonald M.J., and Towle H.C. Isolation and characterization of rat cDNA clones for two distinct thyroid hormone receptors. J. Biol. Chem. 263 (1988) 12770-12777